239 related articles for article (PubMed ID: 18058264)
1. Endocrine precursor lesions of gastroenteropancreatic neuroendocrine tumors.
Klöppel G; Anlauf M; Perren A
Endocr Pathol; 2007; 18(3):150-5. PubMed ID: 18058264
[TBL] [Abstract][Full Text] [Related]
2. Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1: criteria, molecular concepts and clinical significance.
Anlauf M; Perren A; Klöppel G
Pathobiology; 2007; 74(5):279-84. PubMed ID: 17890894
[TBL] [Abstract][Full Text] [Related]
3. Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions.
Anlauf M; Perren A; Henopp T; Rudolf T; Garbrecht N; Schmitt A; Raffel A; Gimm O; Weihe E; Knoefel WT; Dralle H; Heitz PU; Komminoth P; Klöppel G
Gut; 2007 May; 56(5):637-44. PubMed ID: 17135306
[TBL] [Abstract][Full Text] [Related]
4. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
5. Precursor lesions of endocrine system neoplasms.
Mete O; Asa SL
Pathology; 2013 Apr; 45(3):316-30. PubMed ID: 23478233
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
[TBL] [Abstract][Full Text] [Related]
7. Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas.
Anlauf M; Perren A; Meyer CL; Schmid S; Saremaslani P; Kruse ML; Weihe E; Komminoth P; Heitz PU; Klöppel G
Gastroenterology; 2005 May; 128(5):1187-98. PubMed ID: 15887103
[TBL] [Abstract][Full Text] [Related]
8. Identification of MEN1 mutations in sporadic enteropancreatic neuroendocrine tumors by analysis of paraffin-embedded tissue.
Mailman MD; Muscarella P; Schirmer WJ; Ellison EC; O'Dorisio TM; Prior TW
Clin Chem; 1999 Jan; 45(1):29-34. PubMed ID: 9895334
[TBL] [Abstract][Full Text] [Related]
9. Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions.
Vanoli A; La Rosa S; Luinetti O; Klersy C; Manca R; Alvisi C; Rossi S; Trespi E; Zangrandi A; Sessa F; Capella C; Solcia E
Hum Pathol; 2013 Sep; 44(9):1827-37. PubMed ID: 23642738
[TBL] [Abstract][Full Text] [Related]
10. Gastric neuroendocrine neoplasms and related precursor lesions.
La Rosa S; Vanoli A
J Clin Pathol; 2014 Nov; 67(11):938-48. PubMed ID: 25053544
[TBL] [Abstract][Full Text] [Related]
11. Endocrine hyperplasia and dysplasia in the pathogenesis of gastrointestinal and pancreatic endocrine tumors.
Rindi G; Solcia E
Gastroenterol Clin North Am; 2007 Dec; 36(4):851-65, vi. PubMed ID: 17996794
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors.
Asa SL; La Rosa S; Basturk O; Adsay V; Minnetti M; Grossman AB
Endocr Pathol; 2021 Mar; 32(1):169-191. PubMed ID: 33459926
[TBL] [Abstract][Full Text] [Related]
13. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
Couvelard A; Scoazec JY
Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
[TBL] [Abstract][Full Text] [Related]
14. Xq25 and Xq26 identify the common minimal deletion region in malignant gastroenteropancreatic endocrine carcinomas.
Azzoni C; Bottarelli L; Pizzi S; D'Adda T; Rindi G; Bordi C
Virchows Arch; 2006 Feb; 448(2):119-26. PubMed ID: 16244870
[TBL] [Abstract][Full Text] [Related]
15. Morphological, molecular, and prognostic aspects of gastric endocrine tumors.
Solcia E; Rindi G; Larosa S; Capella C
Microsc Res Tech; 2000 Mar; 48(6):339-48. PubMed ID: 10738315
[TBL] [Abstract][Full Text] [Related]
16. [Gastrin cell hyperplasia associated with duodenal MEN1-related gastrinomas: histopathology and genetics].
Anlauf M; Perren A; Klöppel G
Verh Dtsch Ges Pathol; 2007; 91():320-9. PubMed ID: 18314630
[TBL] [Abstract][Full Text] [Related]
17. Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.
Rindi G; Villanacci V; Ubiali A
Digestion; 2000; 62 Suppl 1():19-26. PubMed ID: 10940683
[TBL] [Abstract][Full Text] [Related]
18. Spatial profiling reveals tissue-specific neuro-immune interactions in gastroenteropancreatic neuroendocrine tumors.
Duan S; Sawyer TW; Witten BL; Song H; Else T; Merchant JL
J Pathol; 2024 Mar; 262(3):362-376. PubMed ID: 38229586
[TBL] [Abstract][Full Text] [Related]
19. Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2.
Hermann G; Konukiewitz B; Schmitt A; Perren A; Klöppel G
Virchows Arch; 2011 Aug; 459(2):147-54. PubMed ID: 21739268
[TBL] [Abstract][Full Text] [Related]
20. c-MET inhibition: novel treatment for sporadic and MEN1-associated GEP NETs.
Lee ME; Tepede AA; Mandl A; Weinstein LS; Del Rivero J; Agarwal SK; Blau JE
J Mol Endocrinol; 2020 Aug; 65(2):R1-R17. PubMed ID: 32384260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
